OMRON Healthcare's Generous Donation to Blood Pressure Initiatives
OMRON Healthcare Co., Ltd. has taken a significant step in supporting global health by donating approximately 4,000 blood pressure monitors. This initiative is a vital part of their ongoing commitment to public health awareness, particularly for hypertension and related conditions. The donated blood pressure monitors will feature the new AI-based Intellisense AFib technology, which can detect possible atrial fibrillation with each measurement.
Continuing a Legacy of Support
Since its partnership with May Measurement Month (MMM) began in 2017, OMRON has donated around 30,000 blood pressure monitors across over 100 countries. This program aims to educate individuals on the dangers of elevated blood pressure and promote routine monitoring as a crucial aspect of health care. The initiative strives to empower patients to take charge of their health by understanding the risks associated with hypertension and AFib.
The Importance of Monitoring Blood Pressure
Regular blood pressure monitoring is essential for identifying risks associated with hypertension and heart conditions. Professor Neil R Poulter, the Chief Investigator and Chair of Trustees for May Measurement Month, emphasizes the severe risks that atrial fibrillation can pose to individuals with high blood pressure. By providing these monitors, OMRON Healthcare aims to facilitate earlier detection and better management of hypertension, ultimately contributing to saving lives.
The Significance of the May Measurement Month
This year's MMM will take place from May 1 to July 31 and will involve hands-on activities for blood pressure measurement and practical advice on managing blood pressure levels. During this time, participants will be able to assess their AFib risk through advanced features integrated into the donated monitors, which will include ECG recordings.
Raising Awareness about Atrial Fibrillation
Research highlights that the incidence of AFib among hypertensive patients is three times higher than that of individuals with normal blood pressure. By incorporating features that can detect AFib, OMRON is directly addressing a significant risk factor among people with hypertension. This proactive approach should help inform patients of their conditions and the need for further medical evaluation.
The Global Impact of Hypertension
According to the World Health Organization (WHO), high blood pressure is a leading cause of death worldwide, accounting for more than 10 million fatalities annually. Alarmingly, a significant number of those with AFib do not exhibit obvious symptoms initially, underscoring the need for regular health assessments. Monitoring blood pressure at home can play an instrumental role in managing and preventing serious health complications.
OMRON Healthcare's Commitment to Innovation and Health
OMRON Healthcare is dedicated to advancing health globally, empowering individuals to lead fuller lives. With a vision centered on preventive care, OMRON develops a range of medical devices aimed at monitoring and managing various health conditions, particularly focusing on cardiovascular health, remote patient monitoring, and respiratory care. Their commitment to innovation is evident in their broad array of products and services offered in over 130 countries.
Having sold over 350 million units globally, OMRON continues to provide some of the most recommended blood pressure monitors endorsed by healthcare professionals. This remarkable achievement reflects the company's mission to enhance lives through innovative healthcare solutions and community support.
About OMRON Healthcare
Headquartered in Kyoto, Japan, OMRON Healthcare is a leader in developing clinically proven and innovative medical equipment for home health monitoring. Their extensive commitment to improving lives and contributing to social well-being is deeply embedded in their corporate philosophy. As they continue, OMRON remains focused on delivering cutting-edge technology for patients and healthcare professionals alike.
Frequently Asked Questions
What is the Intellisense AFib technology?
The Intellisense AFib technology is designed to detect potential atrial fibrillation during blood pressure measurements, enhancing early detection and management.
Why is May Measurement Month important?
May Measurement Month is crucial for raising awareness about hypertension and promoting regular blood pressure monitoring to prevent serious health complications.
How has OMRON contributed to public health?
OMRON has donated approximately 30,000 blood pressure monitors globally to promote awareness of hypertension and AFib, supporting early detection and treatment.
Where is OMRON Healthcare based?
OMRON Healthcare is headquartered in Kyoto, Japan, and operates in over 130 countries worldwide.
What role does home blood pressure monitoring play?
Home blood pressure monitoring is vital for managing hypertension effectively and can lead to improved health outcomes by enabling individuals to take control of their health.
